Filing Details

Accession Number:
0001144204-17-026397
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-11 14:32:36
Reporting Period:
2017-05-09
Filing Date:
2017-05-11
Accepted Time:
2017-05-11 14:32:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1133869 Capricor Therapeutics Inc. CAPR Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1310611 B David Musket C/O Capricor Therapeutics, Inc.
8840 Wilshire Blvd., 2Nd Floor
Beverly Hills CA 90211
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-09 25,000 $3.10 25,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 70,962 Indirect By SEP FBO David B. Musket
Footnotes
  1. The Reporting Person entered into a Subscription Agreement with Capricor Therapeutics, Inc. (the "Issuer") pursuant to which the Reporting Person, on May 5, 2017 purchased an aggregate of 25,000 shares of the Issuer's common stock at a purchase price of $3.10 per share for total cash proceeds of approximately US$77,500.
  2. The shares of the Issuer's common stock are held by the Reporting Person's IRA.